Over 90% of ccRCC tumors harbor von Hippel-Lindau (VHL) mutations that stabilize hypoxia-inducible factors (HIFs) even under normoxia (Nickerson et al., 2008). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.